Visiopharm is a world leader in Augmented Pathology™ solutions; quantitative image analysis and Powering Artificial intelligence for Digital Pathology with Deep Learning. Leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, and hospital diagnostic pathology labs all over the world utilize the Oncotopix® platform for tissue-based research and diagnostics. The Oncotopix® Diagnostics solution is based on the latest technological advances in digital image analysis utilizing Artificial Intelligence (AI), Machine Learning and Deep Learning as its foundation. Oncotopix® provides scientists and pathologist with a scalable software solution that fits the needs and volumes of both research and diagnostic labs. Over the past years Visiopharm has grown into an international business with over 900 installations and countless new users. Since 2010 Visiopharm software has been featured in over 1200 scientific publications and is compatible with leading slide scanning systems and data management software. A growing network of authorized distributors and integration partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Our headquarters is located in the Medicon Valley of Denmark, with a branch office in the United Kingdom, as well as a North American office in Broomfield, Colorado.